National Institutes of Health: Autistic Disorder trials

The registry lists 26 Autistic Disorder studies with National Institutes of Health as lead sponsor. 1 are open to participants now and 4 have results posted.

Phase 1 4Phase 2 7Phase 3 3Phase 4 1No phase 14(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• The Neurodevelopmental and Behavioral Phenotyping Screening ProtocolRecruitingNCT00271622
• A Trial of the Drug Donepezil for Sleep Enhancement and Behavioral Change in Children With AutismTerminatedNCT01887132Phase 2Results posted
• The Effect of Donepezil (Aricept(Registered Trademark)) on REM Sleep in Children With AutismCompletedNCT00695136Phase 1/2Results posted
• Minocycline to Treat Childhood Regressive AutismCompletedNCT00409747Phase 4Results posted
• Riluzole to Treat Child and Adolescent Obsessive-Compulsive Disorder With or Without Autism Spectrum DisordersCompletedNCT00251303Phase 2Results posted
• Near-infrared Spectroscopy and Electroencephalography to Assess Cortical Activation During Motor Tasks in Infants and Toddlers With and Without Cerebral PalsyTerminatedNCT03434080
• Studying Childhood-onset Behavioral, Psychiatric, and Developmental DisordersCompletedNCT01778504
• Near Infrared Spectroscopy in Children With Autism and ADHDTerminatedNCT01730079
• Study of Toddlers With Language DelayCompletedNCT01339767
• A Study of the Association Between Autism and Immune Changes in the BrainTerminatedNCT01322555
• A Study of Divalproex Sodium in Children With ASD and Epileptiform EEGWithdrawnNCT01170325Phase 2
• A Coping Effectiveness Training Intervention for Caregivers of Children With Autism Spectrum: A Feasibility StudyCompletedNCT01168284Not applicable
• Brain Imaging Study of Adults With Autism Spectrum DisordersCompletedNCT01093768Phase 1
• Exome Sequencing in Autistic Spectrum DisorderCompletedNCT01059201
• Cognitive Neuroscience of Autism Spectrum DisordersCompletedNCT01031407
• Optimizing Social and Communication Outcomes for Toddlers With AutismCompletedNCT00999778Not applicable
• Cholesterol in ASD: Characterization and TreatmentCompletedNCT00965068Phase 1/2
• Identification of Characteristics Associated With Symptom Remission in AutismCompletedNCT00938054
• Mercury Chelation to Treat AutismWithdrawnNCT00376194Phase 2
• Clinical and Immunological Investigations of Subtypes of AutismCompletedNCT00298246
• Childhood Autism Risks From Genetics and the Environment (The CHARGE Study)CompletedNCT00106652
• Secretin for the Treatment of AutismCompletedNCT00065962Phase 3
• Improving Attention Skills of Children With AutismCompletedNCT00065910Phase 1/2
• Valproate Response in Aggressive Autistic AdolescentsStatus unknownNCT00065884Phase 3
• Methylphenidate in Children and Adolescents With Pervasive Developmental DisordersCompletedNCT00025779Not applicable
• Treatment of Autism in Children and AdolescentsCompletedNCT00005014Phase 3